Detected ·
E2 - Endovascular Engineering
——
E2 - Endovascular Engineering raised $80M Series C co-led by Norwest Venture Partners and Gilde Healthcare for their next-generation Hēlo® Thrombectomy Platform designed to remove blood clots while delivering safer treatment for pulmonary embolism.
- Website
- www.e2helo.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-07 15:09:23 UTC
- Signal ID
- 8a65ee91-e6c8-4d7c-b918-3584d5dcaf7e
As the API returns it
{
"id": "8a65ee91-e6c8-4d7c-b918-3584d5dcaf7e",
"created_at": "2026-04-07T15:09:23.578093Z",
"company_name": "E2 - Endovascular Engineering",
"company_website_url": "www.e2helo.com",
"company_linkedin_url": "https://www.linkedin.com/company/endovascular-engineering",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*E2 - Endovascular Engineering raised $80M Series C co-led by Norwest Venture Partners and Gilde Healthcare for their next-generation Hēlo® Thrombectomy Platform designed to remove blood clots while delivering safer treatment for pulmonary embolism.*"
}